Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
2,949.00    -78.00 (-2.58%)
Bid:
2,942.00
Ask:
2,946.00
Spread: 4.00 (0.136%)
Market Cap: £4.11b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Acquisition

1 Dec 2015 07:00

RNS Number : 4624H
Croda International PLC
01 December 2015
 

 

1 December 2015

 

CRODA INTERNATIONAL PLC

 

Acquisition of Innovative Seed Enhancement Business Incotec Group B.V.

 

Croda International Plc ('Croda') today announces that it has agreed to acquire Incotec Group B.V. ('Incotec'), an independent world leader of innovative seed enhancement, headquartered in Enkhuizen in the Netherlands. The total consideration, inclusive of debt, is €155 million (£109m). The acquisition is expected to complete on 4 December 2015.

 

Founded in 1968, Incotec develops and supplies a wide range of proprietary and sustainable technologies for both vegetable seeds and field crops. It operates in one of the fastest growing segments within the crop care market. Incotec's products and services help to enhance and improve seed performance, allowing greater efficacy and functionality to be delivered directly by the seed. Incotec is a technology rich, capital light, knowledge based business, which for the year ended 30 September 2015 reported (unaudited) revenues of €71million.

 

Seed enhancement has been identified as a key market opportunity for Croda's Crop Care business. Through the acquisition of Incotec, the technical and formulation expertise of both parties will be further exploited. This will add innovative seed enhancement technologies to Croda's existing portfolio of high performance adjuvants and formulation aids. Supported by enlarged and enriched research and technical capabilities and a dedicated global sales force, Croda will offer a broader, more innovative portfolio of products to its customers. This will help in feeding the world's growing population by improving farming yields. Supported by further investment from Croda, the Incotec business will retain its independent identity and strong brand.

 

Steve Foots, Chief Executive of Croda, commented:

 

"Incotec is a rare asset in a niche, high value, fast growing sector of the global crop market. With an experienced research and development led management team, Incotec brings differentiated market leading technologies, world class innovation and strong customer relationships. The combination with our own Crop Care business creates a strong and unique platform for future growth. We believe that our combined innovation strengths, together with our global sales reach, will enable us to be far more responsive in meeting the unmet needs of our customers today and tomorrow."

 

 

Further information:

 

Jez Maiden, Group Finance Director Tel: +44 1405 860551

Conleth Campbell, VP Investor Relations Tel: +44 1405 860551

Charlie Armitstead, Pendomer Communications Tel: +44 7703 330 269

 

About Incotec:

Incotec is a leading player in the field of seed enhancement globally, servicing multinational and local seed producers. Incotec adds value to the seed and crop protection industry value chain by providing a range of technologies and services for seed coating, pelleting, seed enhancement and analytical services for genetic analysis and quality inspection. Incotec has a long track record as an innovative leader in the industry, supported by a highly qualified research and development team dedicated to seed enhancement and related technologies.

www.incotec.com

 

About Croda Crop Care:

Croda is the name behind the high performance ingredients and technologies in some of the biggest, most successful brands in the world: creating, making and selling speciality chemicals that are relied on by industries and consumers everywhere. With more than 3,600 employees working in over 30 countries, Croda focuses on developing and delivering a wide range of practical solutions to its customers across nine markets. Within Crop Care, Croda produces high performance adjuvants and formulation aids for the crop protection industry. Its unique formulation expertise helps crop protection customers get the best performance out of their active ingredients, enabling farmers to improve yields from their crops.

www.croda.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQBMBRTMBIJBRA
Date   Source Headline
1st Jun 20261:46 pmRNSDirector/PDMR Shareholding
29th May 20264:06 pmRNSDirector/PDMR Shareholding
29th May 20263:10 pmRNSDirector/PDMR Shareholding
29th May 20261:53 pmRNSDirector/PDMR Shareholding
29th May 20261:52 pmRNSDirector/PDMR Shareholding
29th May 20261:45 pmRNSDirector/PDMR Shareholding
15th May 20269:23 amRNSDirector/PDMR Shareholding
12th May 202612:10 pmRNSDirector/PDMR Shareholding
6th May 20261:21 pmRNSDirector/PDMR Shareholding
23rd Apr 202611:20 amRNSResult of AGM
22nd Apr 20267:00 amRNSFirst quarter 2026 sales in line with expectations
13th Apr 20261:41 pmRNSDirector/PDMR Shareholding
31st Mar 202611:48 amRNSHolding(s) in Company
26th Mar 20264:34 pmRNSDirector/PDMR Shareholding
18th Mar 20263:31 pmRNSDirector/PDMR Shareholding
18th Mar 20263:30 pmRNSDirector/PDMR Shareholding
18th Mar 20263:27 pmRNSDirector/PDMR Shareholding
18th Mar 20263:25 pmRNSDirector/PDMR Shareholding
18th Mar 20263:23 pmRNSDirector/PDMR Shareholding
18th Mar 20263:23 pmRNSDirector/PDMR Shareholding
18th Mar 20263:20 pmRNSDirector/PDMR Shareholding
16th Mar 20261:36 pmRNSAnnual Financial Report
16th Mar 20261:36 pmRNSAnnual Financial Report
11th Mar 202611:28 amRNSDirector/PDMR Shareholding
11th Mar 202611:28 amRNSDirector/PDMR Shareholding
6th Mar 20261:32 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:13 pmRNSHolding(s) in Company
24th Feb 20267:00 amRNSResults for the year ended 31 December 2025
11th Feb 20262:59 pmRNSDirector/PDMR Shareholding
13th Jan 20262:47 pmRNSDirector/PDMR Shareholding
9th Jan 20267:00 amRNSDirector Declaration
11th Dec 202511:30 amRNSDirector/PDMR Shareholding
11th Nov 202511:19 amRNSDirector/PDMR Shareholding
16th Oct 20257:00 amRNSThird quarter 2025 sales update
14th Oct 20251:58 pmRNSDirector/PDMR Shareholding
8th Oct 20254:26 pmRNSDirector/PDMR Shareholding
1st Oct 20253:45 pmRNSDirector/PDMR Shareholding
18th Sep 20253:49 pmRNSHolding(s) in Company
12th Sep 202510:11 amRNSDirector/PDMR Shareholding
11th Sep 20253:54 pmRNSDirector/PDMR Shareholding
29th Aug 20253:58 pmRNSHolding(s) in Company
29th Aug 202511:03 amRNSHolding(s) in Company
27th Aug 20251:58 pmRNSHolding(s) in Company
22nd Aug 20254:24 pmRNSDirector/PDMR Shareholding
22nd Aug 202511:55 amRNSDirector/PDMR Shareholding
14th Aug 20259:10 amRNSDirector/PDMR Shareholding
12th Aug 202511:42 amRNSDirector/PDMR Shareholding
7th Aug 20259:16 amRNSDirector/PDMR Shareholding
4th Aug 20253:21 pmRNSDirector/PDMR Shareholding
4th Aug 202511:03 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.